Details for Patent: 5,670,675
✉ Email this page to a colleague
| Title: | Retroviral protease inhibiting compounds |
| Abstract: | A retroviral protease inhibiting compound of the formula A-X-B or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group; A is (1) substituted amino, (2) substituted carbonyl, (3) functionalized imino, (4) functionalized alkyl, (5) functionalized acyl, (6) functionalized heterocyclic or (7) functionalized (heterocyclic)alkyl; and B is (1) substituted carbonyl independently defined as herein, (2) substituted amino independently defined as herein, (3) functionalized imino independently defined as herein, (4) functionalized alkyl independently defined as herein, (5) functionalized acyl independently defined as herein, (6) functionalized heterocyclic independently defined as herein or (7) functionalized (heterocyclic)alkyl independently defined as herein. |
| Inventor(s): | Kempf; Dale J. (Lake Villa, IL), Norbeck; Daniel W. (Lindenhurst, IL) |
| Assignee: | Abbott Laboratories (Abbott Park, IL) |
| Filing Date: | Mar 23, 1995 |
| Application Number: | 08/409,365 |
| Claims: | 1. A compound of the formula: ##STR525## wherein at each occurrence R.sub.3 is independently selected from the group consisting of (i) C.sub.1 -to-C.sub.6 -loweralkyl, (ii) aryl, (iii) (aryl)-C.sub.1 -to-C.sub.6 -alkyl, (iv) C.sub.3 -to-C.sub.7 -cycloalkyl and (v) C.sub.3 -to-C.sub.7 -cycloalkyl-C.sub.1 -to-C.sub.6 -alkyl R.sub.9 is independently selected at each occurrence from the group consisting of hydrogen and aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.17 at each occurrence is independently selected from the group consisting of C.sub.1 -to-C.sub.6 -loweralkyl, aryl and aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.800 is --O--; and at each occurrence h is independently selected from the group consisting of 0 and 1; wherein at each occurrence aryl is independently selected from phenyl, naphthyl, tetrahydronaphthyl, indanyl, tetrafluorophenyl and pentafluorophenyl and wherein the phenyl, naphthyl, tetrahydronaphthyl and indanyl rings are unsubstituted or substituted with one, two or three substitutents independently selected from the group consisting of C.sub.1 -to-C.sub.6 -loweralkyl, halo-C.sub.1 -to-C.sub.6 -alkyl, C.sub.1 -to-C.sub.6 -alkoxy, C.sub.1 -to-C.sub.6 -thioalkoxy, amino, C.sub.1 -to-C.sub.6 -alkylamino, di-C.sub.1 -to-C.sub.6 -alkylamino, hydroxy, halo, mercapto, nitro, carboxaldehyde, carboxy, carbo-C.sub.1 -to-C.sub.6 -alkoxy and carboxamide; or a pharmaceutically acceptable salt thereof. 2. A compound according to claim 1 of the formula: ##STR526## wherein at each occurrence R.sub.3 is independently selected from the group consisting of C.sub.1 -to-C.sub.6 -loweralkyl, C.sub.3 -to-C.sub.7 -cycloalkyl, C.sub.3 -to-C.sub.7 -cycloalkyl-C.sub.1 -to-C.sub.6 -alkyl, aryl and aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.9 is independently selected at each occurrence from the group consisting of hydrogen and aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.17 at each occurrence is independently selected from the group consisting of C.sub.1 -to-C.sub.6 -loweralkyl, aryl and aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.800 is --O--; and at each occurrence h is independently selected from the group consisting of 0 and 1; or a pharmaceutically acceptable salt thereof. 3. A compound according to claim 1 of the formula: ##STR527## wherein at each occurrence R.sub.3 is independently selected from the group consisting of aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.9 is independently selected at each occurrence from the group consisting of hydrogen and aryl-C.sub.1 -to-C.sub.6 -alkyl; R.sub.17 at each occurrence is independently selected from the group consisting of C.sub.1 -to-C.sub.6 -loweralkyl, aryl and arylC.sub.1 -to-C.sub.6 -alkyl; R.sub.800 is --O--; and at each occurrence h is independently selected from the group consisting of 0 and 1; or a pharmaceutically acceptable salt thereof. 4. A compound selected from the group consisting of: 2-(N-benzyl-N-(benzyloxycarbonyl)amino)-5-(t-butyloxycarbonylamino)-1,6-dip henyl-3-hexene-3,4-oxide; 2-amino-5-(t-butyloxycarbonylamino)-1,6-diphenyl-3-hexene-3,4-oxide; and 2,5-di-(t-butyloxycarbonylamino)-1,6-diphenyl-3-hexene-3,4-oxide. |
